封面
市場調查報告書
商品編碼
1538433

藥品折扣卡市場報告:2030 年趨勢、預測與競爭分析

Drug Discount Card Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

藥品折扣卡趨勢與預測

到 2030 年,全球藥品折扣卡市場預計將達到 247 億美元,2024 年至 2030 年複合年成長率為 8.2%。該市場的主要促進因素是網上藥局的激增和處方藥價格的上漲。全球藥品折扣卡市場的未來看起來充滿希望,心血管、糖尿病、止痛藥、精神科和癌症市場都有機會。

按細分市場分類的藥品折扣卡

該研究包括按類型、銷售管道、治療類別和地區對全球藥品折扣卡的預測。

藥品折扣卡市場洞察

Lucintel 預測,品牌藥品卡將在預測期內實現高速成長。

在這個市場中,心血管疾病藥物預計將經歷最高的成長。

預計北美地區在預測期內將出現最高的成長。

常問問題

Q1.市場規模為:

A1. 到 2030 年,全球藥品折扣卡市場預計將達到 247 億美元。

Q2.市場成長預測是多少:

A2. 2024年至2030年,全球藥品折扣卡市場預計將以8.2%的複合年成長率成長。

Q3.影響市場成長的主要促進因素是:

A3.該市場的主要驅動力是網路藥局的滲透率不斷提高以及處方箋藥成本的上升。

Q4.市場的主要細分市場是:

A4. 醫藥優惠卡市場前景廣闊,心血管疾病、糖尿病、止痛藥、心理健康、癌症藥物市場都有機會。

Q5.市場的主要企業是:

A5. 主要的藥品折扣卡公司如下:

  • GoodRx
  • SingleCare
  • WellCard Savings
  • RxSaver
  • Optum Perks
  • Kroger Prescription Savings Club
  • ScriptSave
  • Walmart Rx Savings Program
  • Prescription Hope
  • FamilyWize

Q6.未來最大的細分市場是什麼?

A6.Lucintel 預測,品牌藥品卡將在預測期內實現高速成長。

Q7.未來五年預計哪個地區的市場成長最大?

A7. 預計北美地區在預測期內將出現最高成長。

Q8. 可以客製化報告嗎?

A8. 是的,Lucintel 提供 10% 的客製化服務,無需額外付費。

目錄

第1章執行摘要

第2章全球藥品折扣卡市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球藥品折扣卡市場趨勢(2018-2023)與預測(2024-2030)
  • 全球藥品折扣卡市場:按類型
    • 品牌藥卡
    • 學名藥卡
  • 全球藥品折扣卡市場:依銷售管道
    • 線上
    • 離線
  • 全球藥品折扣卡市場:依治療類別
    • 心血管疾病藥物
    • 糖尿病藥物
    • 鎮痛劑
    • 心理健康藥物
    • 癌症治療藥物
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球藥品折扣卡市場(按地區)
  • 北美藥品折扣卡市場
  • 歐洲藥品折扣卡市場
  • 亞太藥品折扣卡市場
  • 其他地區醫藥優惠卡市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
  • 全球藥品折扣卡市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球醫藥折扣卡市場容量擴張
    • 全球醫藥折扣卡市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • GoodRx
  • SingleCare
  • WellCard Savings
  • RxSaver
  • Optum Perks
  • Kroger Prescription Savings Club
  • ScriptSave
  • Walmart Rx Savings Program
  • Prescription Hope
  • FamilyWize
簡介目錄

Drug Discount Card Trends and Forecast

The future of the global drug discount card market looks promising with opportunities in the cardiovascular drug, diabetes drug, pain medication, mental health medication, and cancer drug markets. The global drug discount card market is expected to reach an estimated $24.7 billion by 2030 with a CAGR of 8.2% from 2024 to 2030. The major drivers for this market are rising online adoption of online pharmacy and increasing cost of prescription medications.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Drug Discount Card by Segment

The study includes a forecast for the global drug discount card by type, sales channel, therapeutic category, and region.

Drug Discount Card Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Branded Cards
  • Generic Cards

Drug Discount Card Market by Sales Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Online
  • Offline

Drug Discount Card Market by Therapeutic Category [Shipment Analysis by Value from 2018 to 2030]:

  • Cardiovascular Drug
  • Diabetes Drug
  • Pain Medication
  • Mental Health Medication
  • Cancer Drug
  • Others

Drug Discount Card Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Drug Discount Card Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies drug discount card companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug discount card companies profiled in this report include-

  • GoodRx
  • SingleCare
  • WellCard Savings
  • RxSaver
  • Optum Perks
  • Kroger Prescription Savings Club
  • ScriptSave
  • Walmart Rx Savings Program
  • Prescription Hope
  • FamilyWize

Drug Discount Card Market Insights

Lucintel forecasts that branded card is expected to witness higher growth over the forecast period.

Within this market, cardiovascular drug is expected to witness the highest growth.

North America is expected to witness the highest growth over the forecast period.

Features of the Global Drug Discount Card Market

Market Size Estimates: Drug discount card market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Drug discount card market size by type, sales channel, therapeutic category, and region in terms of value ($B).

Regional Analysis: Drug discount card market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, sales channels, therapeutic categories, and regions for the drug discount card market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the drug discount card market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the drug discount card market size?

Answer: The global drug discount card market is expected to reach an estimated $24.7 billion by 2030.

Q2. What is the growth forecast for drug discount card market?

Answer: The global drug discount card market is expected to grow with a CAGR of 8.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the drug discount card market?

Answer: The major drivers for this market are rising online adoption of online pharmacy and increasing cost of prescription medications.

Q4. What are the major segments for drug discount card market?

Answer: The future of the drug discount card market looks promising with opportunities in the cardiovascular drug, diabetes drug, pain medication, mental health medication, and cancer drug markets.

Q5. Who are the key drug discount card market companies?

Answer: Some of the key drug discount card companies are as follows:

  • GoodRx
  • SingleCare
  • WellCard Savings
  • RxSaver
  • Optum Perks
  • Kroger Prescription Savings Club
  • ScriptSave
  • Walmart Rx Savings Program
  • Prescription Hope
  • FamilyWize

Q6. Which drug discount card market segment will be the largest in future?

Answer: Lucintel forecasts that branded card is expected to witness higher growth over the forecast period.

Q7. In drug discount card market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the drug discount card market by type (branded cards and generic cards), sales channel (online and offline), therapeutic category (cardiovascular drug, diabetes drug, pain medication, mental health medication, cancer drug, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Drug Discount Card Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Drug Discount Card Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Drug Discount Card Market by Type
    • 3.3.1: Branded Cards
    • 3.3.2: Generic Cards
  • 3.4: Global Drug Discount Card Market by Sales Channel
    • 3.4.1: Online
    • 3.4.2: Offline
  • 3.5: Global Drug Discount Card Market by Therapeutic Category
    • 3.5.1: Cardiovascular Drug
    • 3.5.2: Diabetes Drug
    • 3.5.3: Pain Medication
    • 3.5.4: Mental Health Medication
    • 3.5.5: Cancer Drug
    • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Drug Discount Card Market by Region
  • 4.2: North American Drug Discount Card Market
    • 4.2.1: North American Drug Discount Card Market by Type: Branded Cards and Generic Cards
    • 4.2.2: North American Drug Discount Card Market by Therapeutic Category: Cardiovascular drug, Diabetes drug, Pain medication, Mental health medication, Cancer drug, and Others
  • 4.3: European Drug Discount Card Market
    • 4.3.1: European Drug Discount Card Market by Type: Branded Cards and Generic Cards
    • 4.3.2: European Drug Discount Card Market by Therapeutic Category: Cardiovascular drug, Diabetes drug, Pain medication, Mental health medication, Cancer drug, and Others
  • 4.4: APAC Drug Discount Card Market
    • 4.4.1: APAC Drug Discount Card Market by Type: Branded Cards and Generic Cards
    • 4.4.2: APAC Drug Discount Card Market by Therapeutic Category: Cardiovascular drug, Diabetes drug, Pain medication, Mental health medication, Cancer drug, and Others
  • 4.5: ROW Drug Discount Card Market
    • 4.5.1: ROW Drug Discount Card Market by Type: Branded Cards and Generic Cards
    • 4.5.2: ROW Drug Discount Card Market by Therapeutic Category: Cardiovascular drug, Diabetes drug, Pain medication, Mental health medication, Cancer drug, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Drug Discount Card Market by Type
    • 6.1.2: Growth Opportunities for the Global Drug Discount Card Market by Sales Channel
    • 6.1.3: Growth Opportunities for the Global Drug Discount Card Market by Therapeutic Category
    • 6.1.4: Growth Opportunities for the Global Drug Discount Card Market by Region
  • 6.2: Emerging Trends in the Global Drug Discount Card Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Drug Discount Card Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Drug Discount Card Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GoodRx
  • 7.2: SingleCare
  • 7.3: WellCard Savings
  • 7.4: RxSaver
  • 7.5: Optum Perks
  • 7.6: Kroger Prescription Savings Club
  • 7.7: ScriptSave
  • 7.8: Walmart Rx Savings Program
  • 7.9: Prescription Hope
  • 7.10: FamilyWize